Login / Register

CME Event Calendar

CME Online Activities

Other Activities

2009 Peer-to-Peer Dialogues

CME Information

NEEDS STATEMENT/TARGET AUDIENCE
This activity is intended for critical care nurses, emergency physicians, general surgeons, hematologists, hospitalists, and hospital administrators who manage heparin-induced thrombocytopenia (HIT)

EDUCATIONAL ACTIVITY OBJECTIVES
At the conclusion of this activity, participants should be able to:

• Identify risk factors associated with heparin-induced thrombocytopenia (HIT) in the hospital setting and apply this knowledge toward guideline adherence for accurate HIT screening and identification
• Review the most recent guidelines for early recognition and accurate diagnosis of HIT and demonstrate an awareness of the current recommendations surrounding management options
• Utilize practical tools for raising HIT awareness and improving its management in the hospital setting

ACCREDITATION
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION
The France Foundation designates each educational activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Expert Dialogue Delivered By:

Jerrold H. Levy, MD, FAHA
Professor and Deputy Chair for Research, Critical Care and Cardiothoracic Anesthesiology
Director, Cardiothoracic Anesthesiology
Emory University School of Medicine
Atlanta, Georgia

Lawrence Rice, MD
Professor of Medicine
Chief of Hematology
Cornell Weill Medical College-Houston
 
Clinical Service Chief of Hematology/Oncology
The Methodist Hospital
Houston, Texas

Kathleen Shaughnessy, MSN, CRNP, CCRN
Clinical Director, Cardiac Surgery
Porter Institute for Valvular Heart Disease
Abington Memorial Hospital
Abington, Pennsylvania

DISCLOSURES
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.

ACTIVITY STAFF DISCLOSURES
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

FACULTY DISCLOSURES
The following faculty have indicated they have no relationships with industry to disclose relative to the content of this CME activity:

• Kathleen Shaughnessy, MSN, CRNP, CCRN

The following faculty have indicated that they have relationships with industry to disclose:

• Dr. Levy has received grants/research support from Novo and Eli Lilly. He has served as a consultant for CSL Behring, Cubist, The Medicines Company, Novo, and Schering-Plough.
• Dr. Rice is currently participating in a multicenter study sponsored by Canyon Pharma. He has served as a consultant for Canyon Pharma and GlaxoSmithKline. He has received honoraria from Amgen, GlaxoSmithKline, and Novartis.

DISCLAIMER
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and GlaxoSmithKline assume no liability for the information herein.

COMMERCIAL SUPPORT ACKNOWLEDGMENT
This educational activity is supported by an educational grant from GlaxoSmithKline.

HOW TO RECEIVE CREDIT
Upon completion of this activity, please complete the CME Attestation.